Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Clinical trial NCT05071482 · TERMINATED
Trial details
- NCT number
- NCT05071482
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2023-01-16
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.